RecruitingEN originalLeukemia

Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

⚠️

This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.

About the trial

The investigators are doing this research study to assess the percentage of patients receiving stem cell transplantation for the type of blood cancer you have. They want to know how many patients get a transplant and why some patients do get a transplant while others do not. Also they want to explore why some patients elect not to undergo stem cell transplantation, when it is recommended by their physicians.

Original English text from ClinicalTrials.gov

Who can (and can't) join

✓ Qualifies

  • Pacjenci z nowo zdiagnozowaną lub nawrotową ostrą białaczką
  • Pacjenci z zespołami mielodysplastycznymi spełniający kryteria kliniczne
  • Pacjenci z pierwotnym miażdżyca kostną z odpowiednią oceną zaawansowania
  • Wiek od 18 do 80 lat
  • Pacjenci, u których białaczka wróciła po pierwszym przeszczepie komórek
  • Pacjenci wcześniej włączeni do badania, u których chorobą wznowiła się po przeszczepie

✗ Disqualifies

  • Pacjenci z policitemią prawdziwą
  • Pacjenci z samoistnym trombocytozą

Simplified criteria — AI translation

Trial details

Minimum age
18 Years
Maximum age
80 Years
Last updated (source)
July 24, 2026
Sex
No restrictions

Therapies / drugs in trial

Locations (3)

Hartford Healthcare Cancer Institute @ Hartford Hospital

Hartford, United States

Memorial Sloan Kettering Cancer Center

New York, United States

Lehigh Valley Health Network

Allentown, United States

Trial contact

Roni Tamari, MD

Sergio Giralt, MD

Contact information from ClinicalTrials.gov. Contact in English.

Share this trial

Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/26/2026.

You can help another person

We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.